Publication Name	World Journal of Hepatology
Manuscript ID	20884
Country	Canada

Received	2015-06-25 12:58
Peer-Review Started	2015-06-26 21:01
To Make the First Decision	2015-09-08 10:29
Return for Revision	2015-09-11 09:43
Revised	2015-09-25 13:23
Second Decision	2015-12-09 17:11
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-12-18 16:45
Articles in Press	2015-12-18 16:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-12-23 12:47
Publish the Manuscript Online	2015-12-27 14:34

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Management of non-alcoholic fatty liver disease in 2015
Manuscript Source	Invited Manuscript
All Author List	Neel Malhotra and Melanie D Beaton
Funding Agency and Grant Number
Corresponding Author	Dr. Melanie D Beaton, London Health Sciences Centre, University Hospital, Room A10-223, 339 Windermere Road, London, ON N6A 5A5, Canada. melanie.beaton@lhsc.on.ca
Key Words	Lobular inflammation; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Liver fibrosis
Core Tip	Lifestyle modification with diet and exercise remain the mainstay of therapy for nonalcoholic fatty liver disease. Loss of at least 7%-10% of body weight with limiting high fructose corn syrup and high-saturated/high glycemic index foods should be combined with regular, vigorous physical activity. The future of treatment will continue to evolve and likely include the role of anti fibrotic agents, surgical management and transplantation when indicated.
Publish Date	2015-12-27 14:34
Citation	Malhotra N, Beaton MD. Management of non-alcoholic fatty liver disease in 2015. World J Hepatol 2015; 7(30): 2962-2967
URL	http://www.wjgnet.com/1948-5182/full/v7/i30/2962.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i30.2962

Full Article (PDF)	WJH-7-2962.pdf
Full Article (Word)	WJH-7-2962.doc
Manuscript File	20884-Review.docx
Answering Reviewers	20884-Answering reviewers.pdf
Audio Core Tip	20884-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	20884-Conflict-of-interest statement.pdf
Copyright License Agreement	20884-Copyright assignment.pdf
Peer-review Report	20884-Peer-review(s).pdf
Scientific Misconduct Check	20884-Scientific misconduct check.pdf
Scientific Editor Work List	20884-Scientific editor work list.pdf